METASTATIC SOFT-TISSUE SARCOMA
Clinical trials for METASTATIC SOFT-TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOFT-TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC SOFT-TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug shows promise in keeping sarcoma in check
Disease control CompletedThis phase 2 trial tested whether the drug regorafenib (Stivarga) could help keep metastatic soft tissue sarcoma from growing after initial chemotherapy. 127 adults whose cancer was stable or shrinking after six cycles of doxorubicin-based chemo were randomly assigned to receive …
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for sarcoma patients: drug slows tumor growth in late-stage trial
Disease control CompletedThis study tested the drug regorafenib in 219 adults with soft tissue sarcoma that had spread and was no longer responding to standard chemotherapy. Participants were randomly assigned to receive either regorafenib or a placebo. The main goal was to see if the drug could delay ca…
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Immune cells take on sarcoma in early trial
Disease control CompletedThis early-phase trial tested a treatment that uses a patient's own immune cells (called TILs) to fight soft tissue sarcoma. Nine young adults received chemotherapy to prepare their bodies, then an infusion of their own TILs plus high-dose IL-2 to boost the immune response. The m…
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Massive sarcoma study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study looked back at medical records of over 2,100 patients with metastatic soft tissue sarcoma treated in France between 1990 and 2013. Researchers analyzed which treatments patients received, including chemotherapy and local therapies, and how long they lived. The goal is …
Matched conditions: METASTATIC SOFT-TISSUE SARCOMA
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:46 UTC